(Adds details throughout) Nov 13 (Reuters) – Shares of vVardis fell 22% in their NYSE debut on Friday, after the dental health firm raised $175 million in its initial public offering at a price below
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)